Empagliflozin, an SGLT2 inhibitor, is proven safe and effective for heart attack patients, offering a new treatment option to improve outcomes.

In patients hospitalized for medlinkacute myocardial infarction/medlink (MI), the SGLT2 inhibitor empagliflozin offers significant kidney...

Scientists from Western University have discovered a promising molecule found in sweet oranges and tangerines called nobiletin, which may help combat...

When not addressed, the prolonged chronic high blood sugar levels may lead to damaged body systems. This damage is particularly problematic for the...

by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

After eating, the body breaks down carbohydrates into glucose, which is absorbed into the bloodstream. This causes a rise in blood sugar levels. For...

New research shows that around 14% of children and teens in the U.S. either have high blood pressure or are close to developing it. This highlights...

A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...